CN113262182A - 一种眼部保健精华液及其制备方法 - Google Patents
一种眼部保健精华液及其制备方法 Download PDFInfo
- Publication number
- CN113262182A CN113262182A CN202110477031.6A CN202110477031A CN113262182A CN 113262182 A CN113262182 A CN 113262182A CN 202110477031 A CN202110477031 A CN 202110477031A CN 113262182 A CN113262182 A CN 113262182A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- eye
- essence
- medlar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims description 11
- 239000000284 extract Substances 0.000 claims abstract description 175
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 28
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 28
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 28
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 28
- 241000220317 Rosa Species 0.000 claims abstract description 26
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 25
- 240000000249 Morus alba Species 0.000 claims abstract description 22
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 22
- 235000020230 cinnamon extract Nutrition 0.000 claims abstract description 22
- 229940105040 geranium extract Drugs 0.000 claims abstract description 22
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 21
- 235000008113 selfheal Nutrition 0.000 claims abstract description 21
- 244000038594 Phyllanthus urinaria Species 0.000 claims abstract description 19
- 229920000057 Mannan Polymers 0.000 claims abstract description 16
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 16
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 16
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 15
- 239000000230 xanthan gum Substances 0.000 claims abstract description 15
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 15
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 15
- 239000008367 deionised water Substances 0.000 claims abstract description 14
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 14
- 241000628997 Flos Species 0.000 claims description 36
- 241000723353 Chrysanthemum Species 0.000 claims description 24
- 238000001816 cooling Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 239000000017 hydrogel Substances 0.000 claims description 5
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 3
- 241000208152 Geranium Species 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 235000017803 cinnamon Nutrition 0.000 claims description 3
- 239000000287 crude extract Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000000967 suction filtration Methods 0.000 claims description 3
- 239000003860 topical agent Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 36
- 208000003464 asthenopia Diseases 0.000 abstract description 18
- 230000004438 eyesight Effects 0.000 abstract description 10
- 210000004185 liver Anatomy 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 239000003755 preservative agent Substances 0.000 abstract description 5
- 230000004410 intraocular pressure Effects 0.000 abstract description 4
- 230000002335 preservative effect Effects 0.000 abstract description 4
- 238000000222 aromatherapy Methods 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 230000003266 anti-allergic effect Effects 0.000 abstract description 2
- 239000000419 plant extract Substances 0.000 abstract description 2
- 230000002040 relaxant effect Effects 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 239000000686 essence Substances 0.000 description 41
- 239000000047 product Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000032683 aging Effects 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 230000004379 myopia Effects 0.000 description 4
- 208000001491 myopia Diseases 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000003405 preventing effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 206010013774 Dry eye Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000003889 eye drop Substances 0.000 description 2
- 229940012356 eye drops Drugs 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 230000032630 lymph circulation Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提出了一种眼部保健精华液,包括如下重量份的组分:菊花提取物8‑10份、夏枯草提取物6‑8份、桑叶提取物6‑8份、枸杞提取物6‑8份、肉桂提取物4‑6份、叶下珠提取物4‑6份、玫瑰花提取物4‑6份、天竺葵提取物4‑6份、甘露聚糖0.5‑2份、黄原胶0.12‑0.2份、透明质酸钠0.5‑1份、去离子水40‑55份。本发明的眼部保健精华液,巧妙地应用了植物提取物的中药疗效、护肤疗效、香薰疗效,具有舒缓眼疲劳效果好、加快眼部血液循环、降低眼压、清肝明目、放松身心的效果,且有效成分主要来源于天然植物,不添加防腐剂、合成香精等易致敏原,各组分之间具有良好的协同、抗敏、增效作用。
Description
技术领域
本发明涉及眼部护理用品领域,具体涉及一种眼部保健精华液及其制备方法。
背景技术
由于生活水准的提高和信息的飞速更新,工作计算机、娱乐电视等电子产品的使用已非常普及。用眼过度而又缺乏对眼睛的保养而引起视疲劳的人群不断增加,主要表现为眼睛和眉弓部胀痛、眼干、眼涩、视物模糊、流泪、畏光等现象,容易导致眼压的阶段性升高,甚至造成视力下降,给人们的学习、工作和生活带来很大的影响。同时过度用眼和环境因素还造成了眼部周围皮肤松弛,视力下降。因此,能够缓解眼部疲劳和提高眼部视力的产品受到了消费者的青睐。
目前,舒缓眼疲劳产品主要以眼药水为主,效果短暂,持续作用时间短,不易达到舒缓疲劳效果,也缺乏对眼部提供营养的滋养液;频繁滴眼药水更会产生抗药性,对眼睛健康不利。而给眼部肌肤补充水分主要有眼霜、眼膜、眼部精华液等护理眼部肌肤。然而,目前市面上大多数的眼部护理产品针对眼干、眼涩、肌肤缺水、黑眼圈等多方面问题的功效一般,而且含有大量的纯化学合成成分,长期使用存在一定的安全隐患。因此,需要一种安全性高、舒缓眼疲劳效果好、无毒无刺激的眼部保健产品。
发明内容
针对上述问题,本发明的首要目的是提供一种安全性高、舒缓眼疲劳效果好、无毒无刺激的眼部保健精华液及其制备方法。
为解决上述技术问题,本发明所采用的技术方案是:
一种眼部保健精华液,包括如下组分:菊花提取物、夏枯草提取物、桑叶提取物、枸杞提取物、肉桂提取物、叶下珠提取物、玫瑰花提取物、天竺葵提取物、甘露聚糖、黄原胶、透明质酸钠和去离子水。
优选地,一种眼部保健精华液,包括如下重量份的组分:菊花提取物8-10份、夏枯草提取物6-8份、桑叶提取物6-8份、枸杞提取物6-8份、肉桂提取物4-6份、叶下珠提取物4-6份、玫瑰花提取物4-6份、天竺葵提取物4-6份、甘露聚糖0.5-2份、黄原胶0.12-0.2份、透明质酸钠0.5-1份、去离子水40-55份。
优选地,一种眼部保健精华液,包括如下重量份的组分:菊花提取物9份、夏枯草提取物7份、桑叶提取物7份、枸杞提取物7份、肉桂提取物5份、叶下珠提取物5份、玫瑰花提取物5份、天竺葵提取物5份、甘露聚糖1.14份、黄原胶0.16份、透明质酸钠0.7份、去离子水48份。
优选地,所述眼部保健精华液是局部用剂,包括软膏、乳状液体、凝胶、水凝胶或喷雾。
一种眼部保健精华液的制备方法,包括以下步骤:
a、称取原料,备用;
b、将去离子水倒入反应釜加热至温度为100摄氏度,保温30分钟;
c、降温到70-75℃,然后加入黄原胶、透明质酸钠、甘露聚糖,搅拌至完全溶解;
d、降温至40~45℃,然后加入菊花提取物、夏枯草提取物、桑叶提取物、枸杞提取物、肉桂提取物、叶下珠提取物、玫瑰花提取物、天竺葵提取物,继续搅拌20~30分钟后即得到所述眼部保健精华液。
6、根据权利要求1所述的一种眼部保健精华液的制备方法,其特征在于,所述菊花提取物、夏枯草提取物、桑叶提取物、枸杞提取物、肉桂提取物、叶下珠提取物、玫瑰花提取物、天竺葵提取物的制备方法如下:
a、将菊花、夏枯草、桑叶、枸杞、肉桂、叶下珠、玫瑰花、天竺葵花分别进行提取处理,得到菊花、夏枯草、桑叶、枸杞、肉桂、叶下珠、玫瑰花、天竺葵花的粗提取液;
b、将菊花、夏枯草、桑叶、枸杞、肉桂、叶下珠、玫瑰花、天竺葵花的粗提取液分别经24小时静置,然后2000目抽滤得到上清液;
c、将分别得到的上清液进行低温真空浓缩得到稠膏;
d、将稠膏烘干、粉碎,分别得到菊花、夏枯草、桑叶、枸杞、肉桂、叶下珠、玫瑰花、天竺葵花有效成分的提取物,即菊花提取物、夏枯草提取物、桑叶提取物、枸杞提取物、肉桂提取物、叶下珠提取物、玫瑰花提取物、天竺葵提取物。
优选地,所述步骤c中稠膏的相对密度为1.3-1.4。
优选地,所述步骤d中稠膏粉碎后的粒度为100-120目。
优选地,所述菊花提取物具有清热解毒,疏风散热、散瘀,清肝明目,降血压的作用。
所述夏枯草提取物具有清肝泻火,明目,散结消肿、降低血压的作用。
所述桑叶提取物具有疏散风热,清肺润燥,平肝明目,凉血止血,清泄少阳之气热的作用。
所述枸杞提取物含有大量的枸杞多糖、枸杞色素、甜菜碱、微量元素、维生素等营养物质,枸杞多糖具有促进免疫、抗衰老、抗肿瘤、清除自由基、抗疲劳、抗辐射、保肝等作用,枸杞色素主要包括-胡萝卜素、叶黄素和其他有色物质,具有抗氧化、提高人体免疫功能、预防和抑制肿瘤及预防动脉粥样硬化等作用。
所述肉桂提取物具有补火助阳,引火归元,散寒止痛,温通经脉的作用;其特殊香气具有安抚情绪、消除紧张的作用;且具有较强的杀菌作用。
所述叶下珠提取物具有清热解毒、健脾消积、清肝明目的作用。
所述玫瑰花提取物富含多种维生素、葡萄糖、果糖、柠檬酸、苹果酸等营养物质,具有滋养补水、抗老化、平抚皱纹、美白淡斑、缩微红血管、平衡荷尔蒙分泌、舒缓紧张等作用,且具有天然、怡人的芳香。
所述天竺葵提取物能够平衡皮脂分泌、改善毛孔阻塞、调节荷尔蒙、利尿排毒、促进血液及淋巴循环、改善乳房充血及发炎等作用;其气味甜而略重,可纾解压力,平抚焦虑、沮丧,还能提振情绪,让心理恢复平衡。
所述甘露聚糖为天然防腐剂,其无色、无毒、无异味、刺激性低,能够有效防止精华液变质。
所述黄原胶作为增稠剂、稳定剂,且具有抗氧化、防止皮肤衰老的功效。
所述透明质酸钠具有良好的保湿性、修复性、润滑和成膜性,涂抹后可在皮肤表面形成一层薄膜,使皮肤产生良好的光滑感和湿润感,对皮肤起到保护作用。
与现有技术相比,本发明的有益效果是:
1、本发明的眼部保健精华液中,巧妙地应用了植物提取物的中药疗效、护肤疗效、香薰疗效,具有舒缓眼疲劳效果好、加快眼部血液循环、降低眼压、清肝明目、放松身心的效果;且有效成分主要来源于天然植物,不添加防腐剂、合成香精等易致敏原,具有功效显著、安全性高、无毒无刺激性的优点;各组分之间具有良好的协同、抗敏、增效作用。
2、本发明中,
①菊花提取物、夏枯草提取物、桑叶提取物具有滋燥凉血,滋燥凉血、降血压的作用,能够舒缓肝火旺盛、用眼过度引起的眼睛疲劳、眼压过高问题;
②菊花提取物、肉桂提取物、玫瑰花提取物、天竺葵提取物具有天然、怡人的芳香,可作为天然的添香剂使用,能够起到安抚情绪、消除紧张、安抚中枢神经的香疗作用,从而为产品的美容效果起到加成作用;
③菊花提取物、肉桂提取物、叶下珠提取物、玫瑰提取物、天竺葵提取物、枸杞提取物具有促进血液和淋巴循环、清热解毒、清肝明目的作用,能够很好地加快眼部血液循环、舒缓眼疲劳,;
④玫瑰花提取物、天竺葵提取物中的花青素,与枸杞提取物中的叶黄素等类胡萝卜素,以及各提取物中的维生素C具有很好的协同作用,能够满足对营养的需求,从而保护眼睛、缓解眼睛疲劳、唤醒眼睛机能;
⑤玫瑰花提取物、天竺葵提取物、肉桂提取物、枸杞提取物具有良好的滋养补水、抗老化、平抚皱纹、美白淡斑、抗老化、缩微红血管、平衡皮脂分泌的作用,能够很好地滋润眼部肌肤,淡化黑眼圈。
⑥枸杞提取物甜菜碱、菊花提取物中的红没药醇具有良好的抗敏消炎、降低刺激过敏、保护细胞平衡的作用。
3、本产品采用甘露聚糖作为天然防腐剂,且添加的肉桂提取物具有较强的杀菌作用,可以有效提高眼部精华液的抗菌能力,避免了纯化学防腐剂的添加,提高眼部精华液的使用安全性。
4、本发明的制备过程简单,不需要复杂的机器设备。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。
实施例1:
一种眼部保健精华液,包括如下重量份的组分:
菊花提取物9份、夏枯草提取物7份、桑叶提取物7份、枸杞提取物7份、肉桂提取物5份、叶下珠提取物5份、玫瑰花提取物5份、天竺葵提取物5份、甘露聚糖1.14份、黄原胶0.16份、透明质酸钠0.7份、去离子水48份。
具体地,所述眼部保健精华液是局部用剂,包括软膏、乳状液体、凝胶、水凝胶或喷雾;具体的精华液状态或使用时制备成何种产品根据要求而定。
实施例2:
一种眼部保健精华液,包括如下重量份的组分:
菊花提取物8份、夏枯草提取物6份、桑叶提取物6份、枸杞提取物6份、肉桂提取物4份、叶下珠提取物4份、玫瑰花提取物6份、天竺葵提取物6份、甘露聚糖0.5份、黄原胶0.2份、透明质酸钠1份、去离子水52.3份。
实施例3:
一种眼部保健精华液,包括如下重量份的组分:
菊花提取物10份、夏枯草提取物8份、桑叶提取物8份、枸杞提取物8份、肉桂提取物6份、叶下珠提取物6份、玫瑰花提取物4份、天竺葵提取物4份、甘露聚糖2份、黄原胶0.12份、透明质酸钠0.5份、去离子水43.38份。
实施例4:
一种眼部保健精华液,包括如下重量份的组分:
菊花提取物10份、夏枯草提取物8份、桑叶提取物8份、枸杞提取物8份、肉桂提取物6份、叶下珠提取物6份、玫瑰花提取物6份、天竺葵提取物6份、甘露聚糖1.14份、黄原胶0.16份、透明质酸钠0.7份、去离子水40份。
实施例5:
一种眼部保健精华液的制备方法,包括以下步骤:
a、称取原料,备用;
b、将去离子水倒入反应釜加热至温度为100摄氏度,保温30分钟;
c、降温到70-75℃,然后加入黄原胶、透明质酸钠、甘露聚糖,搅拌至完全溶解;
d、降温至40~45℃,然后加入菊花提取物、夏枯草提取物、桑叶提取物、枸杞提取物、肉桂提取物、叶下珠提取物、玫瑰花提取物、天竺葵提取物,继续搅拌20~30分钟后即得到所述眼部保健精华液。
6、根据权利要求1所述的一种眼部保健精华液的制备方法,其特征在于,所述菊花提取物、夏枯草提取物、桑叶提取物、枸杞提取物、肉桂提取物、叶下珠提取物、玫瑰花提取物、天竺葵提取物的制备方法如下:
a、将菊花、夏枯草、桑叶、枸杞、肉桂、叶下珠、玫瑰花、天竺葵花分别进行提取处理,得到菊花、夏枯草、桑叶、枸杞、肉桂、叶下珠、玫瑰花、天竺葵花的粗提取液;
b、将菊花、夏枯草、桑叶、枸杞、肉桂、叶下珠、玫瑰花、天竺葵花的粗提取液分别经24小时静置,然后2000目抽滤得到上清液;
c、将分别得到的上清液进行低温真空浓缩得到稠膏,稠膏的相对密度为1.3-1.4;
d、将稠膏烘干、粉碎,分别得到菊花、夏枯草、桑叶、枸杞、肉桂、叶下珠、玫瑰花、天竺葵花有效成分的提取物,即菊花提取物、夏枯草提取物、桑叶提取物、枸杞提取物、肉桂提取物、叶下珠提取物、玫瑰花提取物、天竺葵提取物;其中,稠膏粉碎后的粒度为100-120目。
以上仅介绍了眼部保健精华液的制备方法,而精华液的状态并不局限于水凝胶的状态,它可以通过其他的制备方法,或者参照水凝胶的制备方法做出一定的调整,从而制备成不同状态的产品来使用,如眼贴、眼膜、走珠液或其他类似的眼部护理产品,具体的精华液状态或使用时制备成何种产品根据要求而定。
测试实验:
功效测试:
1、实验人群:
共50名年龄在15至35岁之间;能很好配合实验者,在研究期间能保持生活的规律性;20名实力正常的志愿者,15名轻度近视的志愿者(近视度数小于等于300度),15名重度近视的志愿者(近视度数大于300度),共50名。
2、测试方法:
实验范围为左右眼眶周围肌肤。规范受试者或护理者每天早晚坚持使用精华液,连续进行2周。实验结束后,请受试者做出精华液对眼部保健效果的评价。
3、研究时间:
整个研究为期14天研究者在第0天、7天、14天进行临床测试结果评估。
4、测试组分评估:
经过实验验证,50人均未发生过敏现象,使用过程中未发生不良反应。
经过7天的使用,50人中:其中17人认为精华液舒缓眼部疲劳效果、护肤效果显著;22人认为精华液舒缓眼部疲劳效果显著,护肤效果一般;8人认为精华液舒缓眼部疲劳效果一般,护肤效果显著;3人认为精华液舒缓眼部疲劳效果、护肤效果一般。
经过7天的使用,50人中:其中24人认为精华液舒缓眼部疲劳效果、护肤效果显著;23人认为精华液舒缓眼部疲劳效果显著,护肤效果一般;3人认为精华液舒缓眼部疲劳效果一般,护肤效果显著;0人认为精华液舒缓眼部疲劳效果、护肤效果一般。
以上所述仅为本发明的较佳受试者而已,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (6)
1.一种眼部保健精华液,其特征在于:包括如下组分:菊花提取物、夏枯草提取物、桑叶提取物、枸杞提取物、肉桂提取物、叶下珠提取物、玫瑰花提取物、天竺葵提取物、甘露聚糖、黄原胶、透明质酸钠和去离子水。
2.根据权利要求1所述的一种眼部保健精华液,其特征在于:包括如下重量份的组分:菊花提取物8-10份、夏枯草提取物6-8份、桑叶提取物6-8份、枸杞提取物6-8份、肉桂提取物4-6份、叶下珠提取物4-6份、玫瑰花提取物4-6份、天竺葵提取物4-6份、甘露聚糖0.5-2份、黄原胶0.12-0.2份、透明质酸钠0.5-1份、去离子水40-55份。
3.根据权利要求1所述的一种眼部保健精华液,其特征在于:包括如下重量份的组分:菊花提取物9份、夏枯草提取物7份、桑叶提取物7份、枸杞提取物7份、肉桂提取物5份、叶下珠提取物5份、玫瑰花提取物5份、天竺葵提取物5份、甘露聚糖1.14份、黄原胶0.16份、透明质酸钠0.7份、去离子水48份。
4.根据权利要求1-3任一项所述的眼部保健精华液,其特征在于,所述眼部保健精华液是局部用剂,包括软膏、乳状液体、凝胶、水凝胶或喷雾。
5.一种眼部保健精华液的制备方法,其特征在于,包括以下步骤:
a、称取原料,备用;
b、将去离子水倒入反应釜加热至温度为100摄氏度,保温30分钟;
c、降温到70-75℃,然后加入黄原胶、透明质酸钠、甘露聚糖,搅拌至完全溶解;
d、降温至40~45℃,然后加入菊花提取物、夏枯草提取物、桑叶提取物、枸杞提取物、肉桂提取物、叶下珠提取物、玫瑰花提取物、天竺葵提取物,继续搅拌20~30分钟后即得到所述眼部保健精华液。
6.根据权利要求1所述的一种眼部保健精华液的制备方法,其特征在于,所述菊花提取物、夏枯草提取物、桑叶提取物、枸杞提取物、肉桂提取物、叶下珠提取物、玫瑰花提取物、天竺葵提取物的制备方法如下:
a、将菊花、夏枯草、桑叶、枸杞、肉桂、叶下珠、玫瑰花、天竺葵花分别进行提取处理,得到菊花、夏枯草、桑叶、枸杞、肉桂、叶下珠、玫瑰花、天竺葵花的粗提取液;
b、将菊花、夏枯草、桑叶、枸杞、肉桂、叶下珠、玫瑰花、天竺葵花的粗提取液分别经24小时静置,然后2000目抽滤得到上清液;
c、将分别得到的上清液进行低温真空浓缩得到稠膏;
d、将稠膏烘干、粉碎,分别得到菊花、夏枯草、桑叶、枸杞、肉桂、叶下珠、玫瑰花、天竺葵花有效成分的提取物,即菊花提取物、夏枯草提取物、桑叶提取物、枸杞提取物、肉桂提取物、叶下珠提取物、玫瑰花提取物、天竺葵提取物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110477031.6A CN113262182A (zh) | 2021-04-30 | 2021-04-30 | 一种眼部保健精华液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110477031.6A CN113262182A (zh) | 2021-04-30 | 2021-04-30 | 一种眼部保健精华液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113262182A true CN113262182A (zh) | 2021-08-17 |
Family
ID=77229824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110477031.6A Pending CN113262182A (zh) | 2021-04-30 | 2021-04-30 | 一种眼部保健精华液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113262182A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105125735A (zh) * | 2015-08-26 | 2015-12-09 | 周占宇 | 一种治疗干眼症的中药组合物 |
CN105687296A (zh) * | 2016-01-31 | 2016-06-22 | 杭州睩客科技有限公司 | 具有眼睛保健作用的挥发性药物 |
CN105796758A (zh) * | 2014-12-31 | 2016-07-27 | 刘桐言 | 一种调理眼部肌肤的护理剂 |
CN106539728A (zh) * | 2017-01-23 | 2017-03-29 | 湖北丽生堂生物科技有限公司 | 一种保湿抗皱缓解视疲劳的叶黄素植物眼霜及制备方法 |
CN110946979A (zh) * | 2019-10-29 | 2020-04-03 | 刘建华 | 一种清肝明目的中药 |
-
2021
- 2021-04-30 CN CN202110477031.6A patent/CN113262182A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105796758A (zh) * | 2014-12-31 | 2016-07-27 | 刘桐言 | 一种调理眼部肌肤的护理剂 |
CN105125735A (zh) * | 2015-08-26 | 2015-12-09 | 周占宇 | 一种治疗干眼症的中药组合物 |
CN105687296A (zh) * | 2016-01-31 | 2016-06-22 | 杭州睩客科技有限公司 | 具有眼睛保健作用的挥发性药物 |
CN106539728A (zh) * | 2017-01-23 | 2017-03-29 | 湖北丽生堂生物科技有限公司 | 一种保湿抗皱缓解视疲劳的叶黄素植物眼霜及制备方法 |
CN110946979A (zh) * | 2019-10-29 | 2020-04-03 | 刘建华 | 一种清肝明目的中药 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108096117B (zh) | 一种组合物及其制备方法和应用 | |
CN111529477A (zh) | 一种用于护理头发的组合物及其制剂和应用 | |
CN109771348B (zh) | 富含天然产物提取成分的美白保湿除皱面霜及其制备方法 | |
CN109044941B (zh) | 一种皮肤紧致滋养保湿组合物及其制备方法和应用 | |
CN112870333A (zh) | 一种改善人脱发生发的组合物、制剂及制备方法和应用 | |
CN104825347A (zh) | 一种医用生物美白袪斑敷料及其制备方法 | |
CN112842943A (zh) | 一种止痒保湿修护肌肤的乳霜及其制备方法 | |
DE202006019184U1 (de) | Feuchtigkeitsspendendes Sanddorn-Hautpflegegel | |
CN110179715B (zh) | 祛黑眼圈组合物、祛黑眼圈眼膜及其制备方法 | |
CN111419770A (zh) | 保湿修复型温感唤醒面膜及其制备方法 | |
CN111973501A (zh) | 一种神经酰胺赋活乳及其制备方法 | |
CN110613663A (zh) | 一种皮肤修护组合物、护肤品及其制备方法 | |
CN107441340B (zh) | 一种消肿止痛止痒滋养皮肤的手足皴裂膏及其制备方法 | |
CN113730272B (zh) | 一种具有缓解眼部疲劳功效的护眼贴及其制备方法 | |
CN113262182A (zh) | 一种眼部保健精华液及其制备方法 | |
KR101757457B1 (ko) | 천연 복합 추출물을 함유하는 열노화 방지 및 피부 진정용 화장료 조성물 | |
CN109157493B (zh) | 一种唇部磨砂膏及其制备方法 | |
CN109602653B (zh) | 具有美白功效的组合物、化妆品、精华液及其制备方法 | |
CN109646359B (zh) | 一种具有清洁净化和美容养颜功效的玫瑰木耳泥膜膏及其制备方法 | |
CN113278477A (zh) | 一种美白保湿滋润抑菌的沐浴皂及其制备方法 | |
CN107693480B (zh) | 一种嫩白滋润的手膜及其制备方法 | |
CN111358733A (zh) | 一种含铁皮石斛提取物的护肤喷雾组合物及其制备和应用 | |
CN110585107A (zh) | 一款能紧致肌肤、滋润、靓丽、深层补水的妙龄精华水及其制备方法 | |
CN115671239B (zh) | 一种抗炎消肿抑菌止痒防裂修复的冻愈膏及其制备方法 | |
CN113368026B (zh) | 一种保湿抗皱滋养护肤凝露及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20211215 Address after: 1-2 / F, 299 / F, 301 / F, 299 Guangfu Middle Road, Liwan District, Guangzhou, Guangdong 510000 Applicant after: Guangzhou vision optical technology Co.,Ltd. Address before: Room 111, room 112, building 10, 1389 Daping village, Sanxing Town, Chongming District, Shanghai Applicant before: Zhenmeili Technology Co.,Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210817 |